Dioxin exposure and its effect on hematopoiesis and cancer have been largely investigated in both human and non-human settings. Here we systematically reviewed literature to address the question of what we know about TCDD biology and exposure. Most effects are due to TCDD interaction with a receptor of xenobiotics called AHR, which is ubiquitously represented and also works on hematopoietic myeloid and lymphoid stem cells, inducing proliferation and stem cell release from bone marrow to peripheral circulation. Epidemiologic studies on TCDD exposure demonstrated an association with onco-hematologic diseases, particularly with non Hodgkin lymphomas and multiple myeloma, and non hematologic cancers, such as sarcomas, although these relationships are affected by multiple confounding factors.
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) role in hematopoiesis and in hematologic diseases: A critical review / N.S. Fracchiolla, C. Annaloro, F. Guidotti, B. Fattizzo, A. Cortelezzi. - In: TOXICOLOGY. - ISSN 0300-483X. - 374(2016), pp. 60-68.
|Titolo:||2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) role in hematopoiesis and in hematologic diseases: A critical review|
FATTIZZO, BRUNO (Penultimo)
CORTELEZZI, AGOSTINO (Ultimo)
|Parole Chiave:||2,3,7,8-Tetrachlorodibenzo-p-dioxin; Aryl hydrocarbon receptor; Hematopoiesis; non Hodgkin lymphoma; Animals; Environmental Pollutants; Hematologic Diseases; Hematopoiesis; Humans; Mice; Polychlorinated Dibenzodioxins; Toxicology|
|Settore Scientifico Disciplinare:||Settore MED/15 - Malattie del Sangue|
|Data di pubblicazione:||2016|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.tox.2016.10.007|
|Appare nelle tipologie:||01 - Articolo su periodico|